Crispino, John D.

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Abdel-Wahab, O., Mullally, A., Hedvat, C., Garcia-Manero, G., Patel, J., Wadleigh, M., Malinge, S., Yao, J., Kilpivaara, O., Bhat, R., et al. (2009) · Blood

Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment

Cited by 727

Control of megakaryocyte‐specific gene expression by GATA‐1 and FOG‐1: role of Ets transcription factors

Wang, X., Crispino, J. D., Letting, D. L., Nakazawa, M., Poncz, M., & Blobel, G. A. (2002) · The EMBO Journal

Genomics and Chromatin DynamicsPlatelet Disorders and Treatments

Cited by 163

USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism

Melo-Cardenas, J., Xu, Y., Wei, J., Tan, C., Kong, S., Gao, B., Montauti, E., Kirsammer, G., Licht, J. D., Yu, J., et al. (2018) · Blood

Acute Myeloid Leukemia ResearchUbiquitin and proteasome pathways

Cited by 84

The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target

Rammohan, M., Harris, E., Bhansali, R. S., Zhao, E., Li, L. S., & Crispino, J. D. (2022) · Oncogene

Cancer Mechanisms and TherapyCancer-related Molecular Pathways

Cited by 68

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development

Zhao, X., Bartholdy, B., Yamamoto, Y., Evans, E. K., Alberich-Jordà, M., Staber, P. B., Benoukraf, T., Zhang, P., Zhang, J., Trinh, B. Q., et al. (2022) · Communications Biology

Genomics and Chromatin DynamicsHematopoietic Stem Cell Transplantation

Cited by 46

An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference

Blobel, G. A., Bodine, D., Brand, M., Crispino, J., de Bruijn, M. F. T. R., Nathan, D., Papayannopoulou, T., Porcher, C., Strouboulis, J., Zon, L., et al. (2015) · Experimental Hematology

Hemoglobinopathies and Related DisordersHemoglobin structure and function

Cited by 9